Susan B. Manoff, Michele Sausser, Amy Falk Russell, Jason Martin, David Radley, Donna Hyatt, . . . Beth-Ann Coller. (2019). Immunogenicity and safety of an investigational tetravalent recombinant subunit vaccine for dengue: Results of a Phase I randomized clinical trial in flavivirus-naïve adults. Taylor & Francis Group.
Chicago Style (17th ed.) CitationSusan B. Manoff, et al. Immunogenicity and Safety of an Investigational Tetravalent Recombinant Subunit Vaccine for Dengue: Results of a Phase I Randomized Clinical Trial in Flavivirus-naïve Adults. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationSusan B. Manoff, et al. Immunogenicity and Safety of an Investigational Tetravalent Recombinant Subunit Vaccine for Dengue: Results of a Phase I Randomized Clinical Trial in Flavivirus-naïve Adults. Taylor & Francis Group, 2019.